|
1
|
Semeraro F, Morescalchi F, Cancarini A,
Russo A, Rezzola S and Costagliola C: Diabetic retinopathy, a
vascular and inflammatory disease: Therapeutic implications.
Diabetes Metab. 45:517–527. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kowluru RA, Kowluru A, Mishra M and Kumar
B: Oxidative stress and epigenetic modifications in the
pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 48:40–61.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simó-Servat O, Simó R and Hernández C:
Circulating biomarkers of diabetic retinopathy: An overview based
on physiopathology. J Diabetes Res. 2016:52637982016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Figueras-Roca M, Molins B,
Sala-Puigdollers A, Matas J, Vinagre I, Ríos J and Adán A:
Peripheral blood metabolic and inflammatory factors as biomarkers
to ocular findings in diabetic macular edema. PLoS One.
12:e01738652017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang J and Kern TS: Inflammation in
diabetic retinopathy. Prog Retin Eye Res. 30:343–358. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zeiner J, Loukovaara S, Losenkova K,
Zuccarini M, Korhonen AM, Lehti K, Kauppinen A, Kaarniranta K,
Müller CE, Jalkanen S and Yegutkin GG: Soluble and membrane-bound
adenylate kinase and nucleotidases augment ATP-mediated
inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
J Mol Med (Berl). 97:341–354. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mishra M, Lillvis J, Seyoum B and Kowluru
RA: Peripheral blood mitochondrial DNA damage as a potential
noninvasive biomarker of diabetic retinopathy. Invest Ophthalmol
Vis Sci. 57:4035–4044. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Blake R and Trounce IA: Mitochondrial
dysfunction and complications associated with diabetes. Biochim
Biophys Acta. 1840:1404–1412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ilkan Z and Akar FG: The mitochondrial
translocator protein and the emerging link between oxidative stress
and arrhythmias in the diabetic heart. Front Physiol. 9:15182018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shoshan-Barmatz V, Pittala S and Mizrachi
D: VDAC1 and the TSPO: Expression, interactions, and associated
functions in health and disease states. Int J Mol Sci. 20:33482019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gatliff J, East D, Crosby J, Abeti R,
Harvey R, Craigen W, Parker P and Campanella M: TSPO interacts with
VDAC1 and triggers a ROS-mediated inhibition of mitochondrial
quality control. Autophagy. 10:2279–2296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou R, Yazdi AS, Menu P and Tschopp J: A
role for mitochondria in NLRP3 inflammasome activation. Nature.
469:221–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Afonina IS, Zhong Z, Karin M and Beyaert
R: Limiting inflammation-the negative regulation of NF-κB and the
NLRP3 inflammasome. Nat Immunol. 18:861–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Swanson KV, Deng M and Ting JPY: The NLRP3
inflammasome: Molecular activation and regulation to therapeutics.
Nat Rev Immunol. 19:477–489. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aiello LP, Avery RL, Arrigg PG, Keyt BA,
Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et
al: Vascular endothelial growth factor in ocular fluid of patients
with diabetic retinopathy and other retinal disorders. N Engl J
Med. 331:1480–1487. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakahira K, Haspel JA, Rathinam VA, Lee
SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim
HP, et al: Autophagy proteins regulate innate immune responses by
inhibiting the release of mitochondrial DNA mediated by the NALP3
inflammasome. Nat Immunol. 12:222–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shimada K, Crother TR, Karlin J, Dagvadorj
J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et
al: Oxidized mitochondrial DNA activates the NLRP3 inflammasome
during apoptosis. Immunity. 36:401–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lv Q, Xu D, Ma J, Wang Y, Yang X, Zhao P,
Ma L, Li Z, Yang W, Liu X, et al: Uric acid drives intestinal
barrier dysfunction through TSPO-mediated NLRP3 inflammasome
activation. Inflamm Res. 70:127–137. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng H, Liu Y, Zhang R, Liang Y, Sun L,
Lan N and Ma B: TSPO ligands PK11195 and midazolam reduce NLRP3
inflammasome activation and proinflammatory cytokine release in
BV-2 cells. Front Cell Neurosci. 14:5444312020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Franceschi C, Garagnani P, Parini P,
Giuliani C and Santoro A: Inflammaging: A new immune-metabolic
viewpoint for age-related diseases. Nat Rev Endocrinol. 14:576–590.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wolf A, Herb M, Schramm M and Langmann T:
The TSPO-NOX1 axis controls phagocyte-triggered pathological
angiogenesis in the eye. Nat Commun. 11:27092020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen H, Zhang X, Liao N, Mi L, Peng Y, Liu
B, Zhang S and Wen F: Enhanced expression of NLRP3
inflammasome-related inflammation in diabetic retinopathy. Invest
Ophthalmol Vis Sci. 59:978–985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wan Z, Fan Y, Liu X, Xue J, Han Z, Zhu C
and Wang X: NLRP3 inflammasome promotes diabetes-induced
endothelial inflammation and atherosclerosis. Diabetes Metab Syndr
Obes. 12:1931–1942. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong Z, Liang S, Sanchez-Lopez E, He F,
Shalapour S, Lin XJ, Wong J, Ding S, Seki E, Schnabl B, et al: New
mitochondrial DNA synthesis enables NLRP3 inflammasome activation.
Nature. 560:198–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song Z, Sun M, Zhou F, Huang F, Qu J and
Chen D: Increased intravitreous interleukin-18 correlated to
vascular endothelial growth factor in patients with active
proliferative diabetic retinopathy. Graefes Arch Clin Exp
Ophthalmol. 252:1229–1234. 2014. View Article : Google Scholar : PubMed/NCBI
|
